Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021
Talis Biomedical Corporation - common stock (TLIS)
Company Research
Source: GlobeNewswire
MENLO PARK, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the third quarter after market close on Monday, November 15, 2021. Talis will host a conference call, beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss financial and operational results. Interested parties may access the live call via telephone by dialing 833-715-1329 for participants in the U.S. or Canada and 430-775-1933 for international callers, using conference ID 3618139. A live and archived webcast of the event can be accessed via the News & Events page of the investor section of Talis Biomedical’s website at www.talis.bio. About Talis Biomedical Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurat
Show less
Read more
Impact Snapshot
Event Time:
TLIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLIS alerts
High impacting Talis Biomedical Corporation - common stock news events
Weekly update
A roundup of the hottest topics
TLIS
News
- Respiratory Infection Diagnostic Technology Market Analysis Report 2024: Multiplex Advancements and Geographic Expansion 2023-2027 - Diagnostic Sector Witnesses Surge [Yahoo! Finance]Yahoo! Finance
- TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
TLIS
Sec Filings
- 4/11/24 - Form 8-K
- 4/1/24 - Form EFFECT
- 3/28/24 - Form 10-K
- TLIS's page on the SEC website